116 related articles for article (PubMed ID: 11606102)
1. Endometrial cancer in women 40 years old or younger.
Duska LR; Garrett A; Rueda BR; Haas J; Chang Y; Fuller AF
Gynecol Oncol; 2001 Nov; 83(2):388-93. PubMed ID: 11606102
[TBL] [Abstract][Full Text] [Related]
2. High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer.
Mauland KK; Trovik J; Wik E; Raeder MB; Njølstad TS; Stefansson IM; Oyan AM; Kalland KH; Bjørge T; Akslen LA; Salvesen HB
Br J Cancer; 2011 Mar; 104(6):921-6. PubMed ID: 21343929
[TBL] [Abstract][Full Text] [Related]
3. How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding.
Smith-Bindman R; Weiss E; Feldstein V
Ultrasound Obstet Gynecol; 2004 Oct; 24(5):558-65. PubMed ID: 15386607
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger.
Ota T; Yoshida M; Kimura M; Kinoshita K
Int J Gynecol Cancer; 2005; 15(4):657-62. PubMed ID: 16014120
[TBL] [Abstract][Full Text] [Related]
5. Profile of women 45 years of age and younger with endometrial cancer.
Evans-Metcalf ER; Brooks SE; Reale FR; Baker SP
Obstet Gynecol; 1998 Mar; 91(3):349-54. PubMed ID: 9491858
[TBL] [Abstract][Full Text] [Related]
6. Risk and predictors of malignancy in women with endometrial polyps.
Wethington SL; Herzog TJ; Burke WM; Sun X; Lerner JP; Lewin SN; Wright JD
Ann Surg Oncol; 2011 Dec; 18(13):3819-23. PubMed ID: 21701931
[TBL] [Abstract][Full Text] [Related]
7. Hormonal therapy for women with stage IA endometrial cancer of all grades.
Park JY; Kim DY; Kim TJ; Kim JW; Kim JH; Kim YM; Kim YT; Bae DS; Nam JH
Obstet Gynecol; 2013 Jul; 122(1):7-14. PubMed ID: 23743459
[TBL] [Abstract][Full Text] [Related]
8. Endometrial carcinoma in women 40 years of age or younger.
Crissman JD; Azoury RS; Barnes AE; Schellhas HF
Obstet Gynecol; 1981 Jun; 57(6):699-704. PubMed ID: 7015203
[TBL] [Abstract][Full Text] [Related]
9. European Society of Gynecological Oncology Task Force for Fertility Preservation: Clinical Recommendations for Fertility-Sparing Management in Young Endometrial Cancer Patients.
Rodolakis A; Biliatis I; Morice P; Reed N; Mangler M; Kesic V; Denschlag D
Int J Gynecol Cancer; 2015 Sep; 25(7):1258-65. PubMed ID: 26186070
[TBL] [Abstract][Full Text] [Related]
10. Comparing transvaginally defined endometrial thickness with hysteroscopic and histopathologic findings in asyptomatic postmenopausal women.
Kalampokas T; Gregoriou O; Grigoriadis C; Iavazzo C; Zervakis A; Sofoudis C; Kalampokas E; Botsis D
Eur J Gynaecol Oncol; 2012; 33(5):508-11. PubMed ID: 23185798
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for uterine cancer in reproductive-aged women.
Lee NK; Cheung MK; Shin JY; Husain A; Teng NN; Berek JS; Kapp DS; Osann K; Chan JK
Obstet Gynecol; 2007 Mar; 109(3):655-62. PubMed ID: 17329517
[TBL] [Abstract][Full Text] [Related]
12. Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification.
Cavaliere AF; Perelli F; Zaami S; D'Indinosante M; Turrini I; Giusti M; Gullo G; Vizzielli G; Mattei A; Scambia G; Vidiri A; Signore F
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830129
[TBL] [Abstract][Full Text] [Related]
13. PPOS Protocol Effectively Improves the IVF Outcome Without Increasing the Recurrence Rate in Early Endometrioid Endometrial Cancer and Atypical Endometrial Hyperplasia Patients After Fertility Preserving Treatment.
Chen J; Cheng Y; Fu W; Peng X; Sun X; Chen H; Chen X; Yu M
Front Med (Lausanne); 2021; 8():581927. PubMed ID: 34386503
[No Abstract] [Full Text] [Related]
14. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).
Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Seong SJ; Kim TJ; Kim JW; Kim SM; Bae DS; Nam JH
Eur J Cancer; 2013 Mar; 49(4):868-74. PubMed ID: 23072814
[TBL] [Abstract][Full Text] [Related]
15. Conservative treatment of endometrial cancer in women of reproductive age (Review).
Bourou MZ; Matsas A; Vrekoussis T; Mastorakos G; Valsamakis G; Panoskaltsis T
Mol Clin Oncol; 2023 Jul; 19(1):55. PubMed ID: 37323245
[TBL] [Abstract][Full Text] [Related]
16. Large Pelvic Mass in a Female Adolescent: Atypical Presentation and Successful Treatment of Extraskeletal Ewing Sarcoma.
Perelli F; Vizzielli G; Cavaliere AF; Restaino S; Scambia G; Zannoni GF; Arciuolo D; Gallotta V
Healthcare (Basel); 2023 May; 11(10):. PubMed ID: 37239656
[TBL] [Abstract][Full Text] [Related]
17. Are women with PCOS more at risk for endometrial cancer? What approach for such patients?
Khalenko VV; Guiglia RA; Alioto M
Acta Biomed; 2023 Apr; 94(2):e2023081. PubMed ID: 37092622
[No Abstract] [Full Text] [Related]
18. Conservative management of early-stage endometrial cancer for fertility preservation: a survey study among Swedish gynecologists and gynecological oncologists.
Iliadis SI; Gambadauro P
Sci Rep; 2023 Apr; 13(1):5861. PubMed ID: 37041242
[TBL] [Abstract][Full Text] [Related]
19. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
Rodolakis A; Scambia G; Planchamp F; Acien M; Di Spiezio Sardo A; Farrugia M; Grynberg M; Pakiz M; Pavlakis K; Vermeulen N; Zannoni G; Zapardiel I; Macklon KLT
Hum Reprod Open; 2023; 2023(1):hoac057. PubMed ID: 36756380
[TBL] [Abstract][Full Text] [Related]
20. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.
Abu-Rustum NR; Yashar CM; Bradley K; Campos SM; Chino J; Chon HS; Chu C; Cohn D; Crispens MA; Damast S; Diver E; Fisher CM; Frederick P; Gaffney DK; George S; Giuntoli R; Han E; Howitt B; Huh WK; Lea J; Mariani A; Mutch D; Nekhlyudov L; Podoll M; Remmenga SW; Reynolds RK; Salani R; Sisodia R; Soliman P; Tanner E; Ueda S; Urban R; Wethington SL; Wyse E; Zanotti K; McMillian NR; Motter AD
J Natl Compr Canc Netw; 2021 Aug; 19(8):888-895. PubMed ID: 34416706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
